| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mirum Pharmaceuticals, Inc. (MIRM) has 13 insiders with recent SEC Form 4 filings, including 6 buys and 6 sells. MIRM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 108.5K | $10.82M | - | |
| CFO | 47.2K | $4.71M | - | |
| COO | 40.3K | $4.02M | - | |
| Other | 18.9K | $1.88M | - | |
| Dir | 3.8K | $376.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2024 | Vig Pamela | Head Of Research &Development | Sell | 1,408 | $28.03 | $39,472.29 | -4.5% | -9.1% | +47.5% | |
| Jan 8, 2024 | Peetz Christopher45 | President And CEO | Sell | 5,209 | $28.03 | $146,033.27 | -4.5% | -9.1% | +47.5% | |
| Jan 8, 2024 | Howe Jolanda | SVP, Global Controller | Sale+OE | 528 | $28.04 | $14,802.53 | -42.2% | -9.1% | +47.5% | |
| Dec 5, 2023 | Howe Jolanda | SVP, Global Controller | Sale+OE | 2,500 | $32.40 | $81,000.00 | -100% | -11.8% | +39.9% | |
| Nov 9, 2023 | Heron Patrick J87 | Director | Buy | 2,910 | $28.30 | $82,353.00 | +1.8% | -6.0% | +47.5% | |
| Sep 14, 2023 | Grey Michael G49 | Director | Sale+OE | 14,608 | $32.00 | $467,456.00 | -100% | +4.8% | +27.1% | |
| Sep 13, 2023 | Heron Patrick J87 | Director | Buy | 2,625 | $31.02 | $81,424.88 | +1.7% | +12.3% | +37.3% | |
| Sep 12, 2023 | Heron Patrick J87 | Director | Buy | 8,437 | $30.44 | $256,791.22 | +2.8% | +3.9% | +34.9% | |
| Sep 11, 2023 | Bjerkholt Eric71 | Chief Financial Officer | Buy | 10,000 | $29.65 | $296,492.00 | New | +6.1% | +37.3% | |
| Aug 31, 2023 | Heron Patrick J87 | Director, 10% Owner | Buy | 147,991 | $26.25 | $3,884,763.75 | New | +19.8% | +63.1% |